Product Name:

NebuSelect™ Recombinant Human BTLA, hFc-tag

Catalog#:

NBL-243004

Description:

NebuSelect™ Recombinant Human BTLA, hFc-tag(Cat#NBL-243004) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Lys31-Ser150.

Species:

Human

Expression System:

HEK293

Molecular Weight: 

The protein has a predicted MW of 40.5 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.

Target Name:

BTLA; CD272; BTLA; BTLA1; FLJ16065; MGC129743

Target Information:

B- and T-lymphocyte attenuator (BTLA; CD272) is a 35 kDa type I transmembrane glycoprotein in the CD28 family of T cell costimulatory molecules. BTLA is a inhibitory receptor on lymphocytes that negatively regulates antigen receptor signaling via PTPN6/SHP-1 and PTPN11/SHP-2. BTLA may interact in cis (on the same cell) or in trans (on other cells) with TNFRSF14.

Amino Acid Sequence: 

Purity:

＞95%

Formulation:

see COA

Endotoxin:

＜1EU/ug(LAL Method)

Storage: 

4°C for short term. 

-20°C for long term.

To get more information, please contact us freely.